UPMC Physician Resources

Rheumatology Our Program

UPMC Rheumatology

UPMC's rheumatology program has a tradition of excellence that goes back 50 years. Our physicians are recognized leaders in diagnosing and treating the vast array of autoimmune disorders, including rare conditions such as systemic sclerosis. Our team has evaluated more than 5,000 scleroderma patients and published over 300 scholarly articles on scleroderma.

UPMC offers five designated specialty clinics for:

  • myositis
  • rheumatoid arthritis/osteoarthritis
  • scleroderma (systemic sclerosis)
  • systemic lupus erythematosus
  • vasculitis

Since 2007, UPMC has ranked among the nation's top 10 rheumatology programs according to the annual U.S. News & World Report survey.

Clinical Research

UPMC rheumatology researchers have developed novel lab tests to better understand autoimmune disorders and clinical options for treating them.

Clinical and basic rheumatology research focuses on:

  • connective tissue disease
  • myositis (including polymyositis and dermatomyositis)
  • osteoarthritis
  • rheumatoid arthritis
  • scleroderma
  • systemic lupus erythematosus
  • vasculitis

We conduct our research through the Multidisciplinary Clinical Research Center for Rheumatic and Musculoskeletal Diseases (MCRC), which consists of more than 100 research projects from more than 50 principal investigators in the rheumatology, health services research, health economics, minority health, geriatrics, and epidemiology disciplines.

Featured Program: Rheumatoid Arthritis Research

Study Shows Equal Efficacy of Drugs vs. Injections for Rheumatoid Arthritis
Biologic injection therapy, the current method of treating rheumatoid arthritis, has helped many patients live with this chronic disease but can be painful, costly, and invasive.

In a comparison of standard treatments for rheumatoid arthritis, UPMC researchers found that less expensive triple-drug therapy is as effective as its more expensive biologic drug-based counterpart is.

These results were presented at the 2009 Annual Scientific Meeting of the American College of Rheumatology, held in Philadelphia, Pa.